Ethyl 3,4-bis(2-methoxyethoxy)benzoate

Ethyl 3,4-bis(2-methoxyethoxy)benzoate 구조식 이미지
카스 번호:
183322-16-9
상품명:
Ethyl 3,4-bis(2-methoxyethoxy)benzoate
동의어(영문):
ERLOTINIBINT-B;Erlotinib interMediate II;Ethyl 3,4-bis(2-methoxyethoxy);3,4-bis(2-methoxyethoxy)benzoate;Erlotinib Hydrochloride iMpurity 30;Thyl3,4-bis(2-methoxyethoxy)benzoate;Ethyl 3,4-bis(2-methoxyethoxy)benzoate;3,-bis(2-methoxyethoxy)-benzoic acid ethyl ester;3,4-Bis(2-methoxyethoxy)benzoic acid ethyl ester;Benzoic acid,3,4-bis(2-Methoxyethoxy)-, ethyl ester
CBNumber:
CB21504002
분자식:
C15H22O6
포뮬러 무게:
298.33
MOL 파일:
183322-16-9.mol

Ethyl 3,4-bis(2-methoxyethoxy)benzoate 속성

녹는점
55-58 °C
끓는 점
401.7±45.0 °C(Predicted)
밀도
1.102
저장 조건
Sealed in dry,Room Temperature
물리적 상태
powder to crystal
색상
흰색에서 거의 흰색

안전

HS 번호 2916.31.5000

Ethyl 3,4-bis(2-methoxyethoxy)benzoate C화학적 특성, 용도, 생산

용도

3,4-bis(2-Methoxyethoxy)benzoic Acid Ethyl Ester is a compound used in the synthesis of Erlotinib (E625008), a cancer treatment medicine.

Ethyl 3,4-bis(2-methoxyethoxy)benzoate 준비 용품 및 원자재

원자재

준비 용품


Ethyl 3,4-bis(2-methoxyethoxy)benzoate 공급 업체

글로벌( 191)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Shanghai Daken Advanced Materials Co.,Ltd
+86-371-66670886
info@dakenam.com China 15928 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Jinan Shengqi pharmaceutical Co,Ltd
86+18663751872
christine@shengqipharm.com CHINA 491 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Jinan Finer Chemical Co., Ltd
+86-531-88989536 +86-15508631887
sales@finerchem.com China 2967 58
Accela ChemBio Inc.
(+1)-858-699-3322
info@accelachem.com United States 19965 58
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63711 58
Shanghai Yingrui Biopharma Co.,Ltd
21-33585366
export01@shyrchem.com CHINA 1320 58

Copyright 2019 © ChemicalBook. All rights reserved